Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0155339 (
Brown
)
12,436
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Intestinal histamine-degrading enzymes diamine oxidase (DAO) and
histamine N-methyltransferase
(
HNMT
) activities are relatively constant per individual and bowel segment, and they reflect the functional integrity of the intestinal mucosa. It was, therefore, hypothesised that a decrease in these enzymes could be indicative of acute rejection of an intestinal allograft. Enzymatic activities of DAO and
HNMT
were determined in mucosal biopsies of isogeneic (Lewis-to-Lewis, n=48) and allogeneic (
Brown
Norway-to-Lewis, n=48) heterotopic small bowel transplants in a rat model at various time periods. Allograft recipients were not given any immunosuppression. While no changes in enzyme activities were observed in isografts up to day 8 following transplantation, significantly reduced activities of both enzymes were found in all allografts 6-8 days after transplantation. Activities of both DAO and
HNMT
exhibited a strong negative correlation with the histological rejection score ( P<0.01). We can conclude that DAO and
HNMT
activities in gut mucosa are reliable quantitative markers of acute intestinal allograft rejection in the rat that support histopathological analysis.
...
PMID:Histamine-degrading enzymes as cellular markers of acute small bowel allograft rejection. 1271 3